This is a StreetInsider.com Premium Only Page

CRISPR Therapeutics (CRSP) –

Apr 22, 2024 04:30 PM CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

Apr 17, 2024 05:45 PM Form 4 CRISPR Therapeutics AG For: Apr 15 Filed by: Kulkarni Samarth

Apr 15, 2024 04:25 PM Form 144 CRISPR Therapeutics AG Filed by: Kulkarni Samarth

Apr 10, 2024 11:59 AM Form SC 13G/A CRISPR Therapeutics AG Filed by: Capital International Investors

Apr 9, 2024 04:48 PM Form ARS CRISPR Therapeutics AG For: Dec 31

Apr 9, 2024 04:44 PM Form DEFA14A CRISPR Therapeutics AG

Apr 9, 2024 04:43 PM Form DEF 14A CRISPR Therapeutics AG For: May 30

Apr 3, 2024 08:00 AM CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference

Apr 1, 2024 08:00 AM CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

Mar 27, 2024 04:32 PM Form PRE 14A CRISPR Therapeutics AG For: May 30

Mar 22, 2024 05:45 PM Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: KASINGER JAMES R.

Mar 22, 2024 05:45 PM Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: Prasad Raju

Mar 22, 2024 05:45 PM Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: Kulkarni Samarth

Mar 22, 2024 04:02 PM Form 144 CRISPR Therapeutics AG Filed by: Morrow Phuong Khanh

Mar 18, 2024 05:45 PM Form 4 CRISPR Therapeutics AG For: Mar 14 Filed by: Prasad Raju

Mar 18, 2024 05:45 PM Form 4 CRISPR Therapeutics AG For: Mar 15 Filed by: Kulkarni Samarth

Mar 15, 2024 04:49 PM Form 144 CRISPR Therapeutics AG Filed by: Kulkarni Samarth

Mar 13, 2024 08:31 AM CRISPR Therapeutics (CRSP) Proposes New Appointment to the Board of Directors

Mar 13, 2024 08:30 AM CRISPR Therapeutics Proposes New Appointment to the Board of Directors

Mar 12, 2024 05:45 PM Form 4 CRISPR Therapeutics AG For: Mar 10 Filed by: KASINGER JAMES R.

Mar 12, 2024 05:45 PM Form 4 CRISPR Therapeutics AG For: Mar 10 Filed by: Kulkarni Samarth

Mar 6, 2024 06:41 AM CRISPR Therapeutics (CRSP) PT Raised to $99 at Mizuho

Feb 27, 2024 06:39 PM Form 4 CRISPR Therapeutics AG For: Feb 27 Filed by: George Simeon

Feb 26, 2024 08:27 AM CRISPR Therapeutics (CRSP) PT Raised to $48 at Morgan Stanley

Feb 22, 2024 07:27 AM CRISPR Therapeutics (CRSP) PT Raised to $70 at Wells Fargo

Feb 22, 2024 06:13 AM CRISPR Therapeutics (CRSP) PT Raised to $66 at RBC Capital

Feb 22, 2024 03:32 AM CRISPR Therapeutics (CRSP) PT Raised to $80 at Barclays

Feb 21, 2024 05:47 PM Form 4 CRISPR Therapeutics AG For: Feb 18 Filed by: KASINGER JAMES R.

Feb 21, 2024 05:47 PM Form 4 CRISPR Therapeutics AG For: Feb 18 Filed by: Kulkarni Samarth

Feb 21, 2024 08:05 AM CRISPR Therapeutics (CRSP) Tops Q4 EPS by 105c

Feb 21, 2024 07:52 AM Form 10-K CRISPR Therapeutics AG For: Dec 31

Feb 21, 2024 07:45 AM Form 8-K CRISPR Therapeutics AG For: Feb 21

Feb 21, 2024 07:30 AM CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 16, 2024 05:45 PM Form 4 CRISPR Therapeutics AG For: Feb 15 Filed by: Kulkarni Samarth

Feb 15, 2024 04:31 PM Form 144 CRISPR Therapeutics AG Filed by: Kulkarni Samarth

Feb 15, 2024 03:43 PM Wolfe Research begins coverage on biotech, names Alpine Immune Sciences as Top Pick

Feb 15, 2024 08:30 AM CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit

Feb 14, 2024 04:19 PM Wolfe Research Starts CRISPR Therapeutics (CRSP) at Peerperform

Feb 13, 2024 06:29 PM Form 8-K CRISPR Therapeutics AG For: Feb 13

Feb 13, 2024 01:35 PM CRISPR Therapeutics (CRSP) PT Raised to $86 at JMP Securities

Feb 13, 2024 08:45 AM Form 424B5 CRISPR Therapeutics AG

Feb 13, 2024 08:31 AM CRISPR Therapeutics (CRSP) Prices $280M Share Offering at $71.50/sh

Feb 13, 2024 08:30 AM CRISPR Therapeutics Announces $280 Million Registered Direct Offering

Feb 13, 2024 06:31 AM Form 8-K CRISPR Therapeutics AG For: Feb 13

Feb 13, 2024 05:56 AM CRISPR Therapeutics (CRSP) Announces EU Approval of CASGEVY

Feb 13, 2024 02:30 AM European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TD

Feb 12, 2024 06:23 PM Form SC 13G/A CRISPR Therapeutics AG Filed by: Nikko Asset Management Americas, Inc.

Feb 9, 2024 06:04 PM Form SC 13G/A CRISPR Therapeutics AG Filed by: Capital International Investors

Feb 7, 2024 02:28 PM CRISPR Therapeutics (CRSP) PT Lowered to $120 at Truist Securities

Feb 5, 2024 06:09 AM Form SC 13G/A CRISPR Therapeutics AG Filed by: Sumitomo Mitsui Trust Holdings, Inc.